To the full analysis
Formycon stock: growth
FYB.DEFormycon reported $49.28M in revenue for fiscal 2025, down 36.2% on the prior year, up 5.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
61.9%
per year from 2009 to 2025, per share 48.9%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2009 | |
|---|---|---|---|
| Revenue | 5.4% | 10.1% | 61.9% |
| Revenue per share | −4.1% | 3.1% | 48.9% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2009 | $22.16K | −$211.65K | −$549.49K |
| 2010 | $54.58K | −$1.12M | −$3.41M |
| 2011 | $0 | −$1.43M | −$183.28K |
| 2012 | $153.39K | −$2.65M | −$3.73M |
| 2013 | $306.03K | −$8.58M | −$18.57M |
| 2014 | $13.95M | $953.33K | −$668.18K |
| 2015 | $18.75M | $639.95K | −$169.43K |
| 2016 | $21.64M | −$4.51M | −$7.05M |
| 2017 | $32.14M | −$1.75M | −$5.1M |
| 2018 | $47.64M | $7.87M | $13.68M |
| 2019 | $36.74M | −$2.54M | −$2.79M |
| 2020 | $37.93M | −$7.46M | −$6.49M |
| 2021 | $40.57M | −$14.73M | −$16.05M |
| 2022 | $47.09M | $39.88M | −$50.7M |
| 2023 | $86.09M | $83.99M | −$12.05M |
| 2024 | $77.21M | −$139.26M | −$58.91M |
| 2025 | $49.28M | −$71.69M | −$48.87M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 14 Feb 2025)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.